A combination of interleukin-2 and 60 nm cationic supramolecular biovectors for the treatment of established tumours by subcutaneous or intranasal administration (Q58854574)
Jump to navigation
Jump to search
scientific article published on 01 May 2001
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A combination of interleukin-2 and 60 nm cationic supramolecular biovectors for the treatment of established tumours by subcutaneous or intranasal administration |
scientific article published on 01 May 2001 |
Statements
A combination of interleukin-2 and 60 nm cationic supramolecular biovectors for the treatment of established tumours by subcutaneous or intranasal administration (English)
S El mir
A Casanova